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166Ultrasound-guided percutaneous thrombin
injection of iatrogenic upper extremity
pseudoaneurysms
Robert P. Garvin, MD, Evan J. Ryer, MD, H. Richard Yoon, MD, J. Brian Kendrick, MD,
Thad J. Neidrick, CRNP, James R. Elmore, MD, and David P. Franklin, MD, Danville, Pa
Objective: The objective of this study was to evaluate the safety and efﬁcacy of ultrasound-guided thrombin injection (TI)
for the treatment of upper extremity iatrogenic pseudoaneurysms (PAs) after percutaneous upper extremity arterial
access.
Methods: This is a retrospective single-institution study from January 2009 to December 2012. All patients with clinical
suspicion of an upper extremity PA after arterial puncture underwent duplex examination. Patients with and without PAs
were compared to identify risk factors for development of PAs. Outcomes were analyzed in those patients with PAs that
were treated with TI.
Results: Between January 1, 2009, and December 31, 2012, there were 61 upper extremity arterial duplex examinations
performed for a clinical suspicion of an upper extremity PA. Eighteen ultrasound examinations (29.5%) demonstrated an
iatrogenic upper extremity PA (13 brachial and ﬁve radial). Those patients with an upper extremity PA were more likely
to have a history of hypertension, atrial ﬁbrillation, and chronic kidney disease. Sheath size, preprocedural antiplatelet
therapy, periprocedural anticoagulation regimen, service specialty performing the procedure, and procedure type did not
inﬂuence the development of PA. Of 18 patients with PA, 14 were treated with TI with an overall success rate of 86%.
There was one PA that failed to thrombose with TI, and there was one native brachial artery thrombosis requiring
emergent surgical intervention. Outpatient clinical follow-up in the successfully treated patients demonstrated no re-
currences at an average follow-up of 8 months.
Conclusions: Ultrasound-guided percutaneous TI appears safe and effective for the treatment of iatrogenic brachial and
radial artery PAs. (J Vasc Surg 2014;59:1664-9.)The concept of treating peripheral artery pseudoa-
neurysms (PAs) with percutaneous thrombin injection
(TI) was ﬁrst reported by Cope and Zeit1 in 1986 in a
case series of four patients. Subsequently, Liau et al2 in
Taiwan and Kang et al3 in the United States reported
their initial experiences with TI of femoral artery PAs.
Later, Kang et al4 expanded the indication to arteries
other than the femoral artery, including seven upper ex-
tremity arterial PAs successfully treated with TI. Similarly,
Krueger et al5 published a report of eight brachial artery
PAs treated with TI in 2005. With the rapid proliferation
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lar Surgery, Hospital for Advanced Medicine.
or conﬂict of interest: none.
ented in preliminary form as a poster at the 2013 Vascular Annual
eeting of the Society for Vascular Surgery, San Francisco, Calif, May
-June 1, 2013. The ﬁnal data for this project were presented at the local
eeting of the Keystone Chapter of the American College of Surgeons
November 8, 2013, in Danville, Pa.
rint requests: Robert P. Garvin, MD, Geisinger Medical Center,
epartment of Vascular and Endovascular Surgery, Hospital for
dvanced Medicine 4th Fl, 100 North Academy Ave, Danville, PA
822 (e-mail: rpgarvin@geisinger.edu or rgarvinmd@yahoo.com).
editors and reviewers of this article have no relevant ﬁnancial relationships
disclose per the JVS policy that requires reviewers to decline review of any
anuscript for which they may have a conﬂict of interest.
-5214/$36.00
yright  2014 by the Society for Vascular Surgery.
://dx.doi.org/10.1016/j.jvs.2014.01.009
4artery access has steadily increased during the past decade
across all disciplines in the United States as well as world-
wide.6 With this increase in upper extremity arterial access
has come a concomitant increase in iatrogenic upper ex-
tremity PAs, but few data exist to document the safety
and efﬁcacy of TI for treatment of these PAs other than
a few case reports and small case series with short-term
follow-up.4,5,7-9
The purpose of this study was to review our experience
with TI for iatrogenic upper extremity PAs to evaluate its
safety and efﬁcacy. On the basis of the aggregate results
from the studies cited, our hypothesis was that TI is safe
and effective for the treatment of upper extremity PAs.
METHODS
This study was approved by the Institutional Review
Board of Geisinger Medical Center. Using a prospectively
maintained database in our Intersocietal Commission for
the Accreditation of Vascular Laboratorieseaccredited
vascular laboratory, we identiﬁed all patients between
January 1, 2009, and December 31, 2012, for whom an
upper extremity arterial duplex examination was performed
to rule out an arterial PA after successful or attempted
upper extremity vascular access that resulted in arterial
puncture. These duplex examinations were ordered selec-
tively by the referring physicians on the basis of clinical sus-
picion for PA; duplex examinations were not performed
routinely on every patient who underwent upper extremity
Fig 1. Typical brachial artery pseudoaneurysm (PA) with to-and-fro
ﬂow or yin-yang sign.
Fig 2. Insertion of 22-gauge spinal needle with stylet by ultra-
sound guidance. PA, pseudoaneurysm.
Fig 3. Successful thrombin injection (TI) demonstrating
continued ﬂow in the native brachial artery with complete
thrombosis of the pseudoaneurysm (PA).
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these cases were peripheral vascular interventions per-
formed by vascular surgeons or cardiac catheterizations
performed by interventional cardiologists.
Demographic, clinical, procedural, imaging, and treat-
ment data were obtained through individual retrospective
chart review of the inpatient and outpatient electronic
health record of each patient. Imaging and TI data
included the size of the PA, amount of thrombin injected,
technical success after injection, and postinjection compli-
cations. Of the patients for whom an ultrasound examina-
tion was ordered to rule out a PA, those patients found to
have a PA were compared with those who did not have a
PA to identify potential risk factors for development of a
PA. All patients underwent repeated arterial duplex exam-
ination the following day after TI. Outpatient clinicalfollow-up with the vascular surgeon was generally per-
formed at 1 month and then routinely thereafter as
dictated by management of the underlying cardiovascular
diseases.
The technique of TI for upper extremity PAs is the
same technique used at our institution for lower extremity
PAs. After a PA has been identiﬁed and the decision is
made to proceed with TI, baseline upper extremity
Doppler waveforms are obtained for the brachial, radial,
and ulnar arteries. With use of real-time duplex ultrasound
(Fig 1), a 22-gauge spinal needle is inserted percutaneously
under sterile conditions into the PA at the junction of the
neck and the sac without the use of a biopsy guide (Fig 2).
The stylet is then removed to ensure that there is back-
bleeding, thereby afﬁrming proper needle tip location
within the PA cavity as visualized on gray-scale imaging.
Next, under color mode imaging, recombinant topical
thrombin (Recothrom; ZymoGenetics Inc, Seattle,
Wash), 5000 IU reconstituted in 5 mL sterile saline, is
slowly injected 100 IU at a time while the pattern of color
ﬂow in the sac is continuously observed. Once the PA
appears to be completely thrombosed as determined by
the disappearance of color ﬂow, the needle is removed,
hemostasis is obtained with manual compression at the
needle insertion site, and a sterile dressing is applied. Post-
injection upper extremity arterial duplex and Doppler
waveforms are then obtained 15 minutes after the injection
to rule out thrombotic or ischemic complications. For
inpatient procedures, the patient is kept in the hospital
overnight for observation with limited activity of the
involved upper extremity, but the extremity is not fully
immobilized. For outpatient procedures, the patient is
sent home with similar instructions and returns to the
vascular surgery clinic the following day. A follow-up arte-
rial duplex examination is performed the following day to
assess for continued thrombosis in the PA cavity (Fig 3)
Table I. Patient demographics
Variable
Negative PA
(n ¼ 43),
No. (%)
Positive PA
(n ¼ 18),
No. (%) P value
Age, years (mean) 66.4 73.1 .055
BMI, kg/m2 31.3 28.1 .174
Male gender 23 (53) 6 (33) .172
Hypertension 33 (77) 18 (100) .026
Diabetes 18 (42) 8 (44) 1.000
Dyslipidemia 40 (93) 15 (83) .348
CAD 32 (74) 14 (78) 1.000
CHF 13 (30) 5 (28) 1.000
Atrial ﬁbrillation 5 (12) 9 (50) .002
Chronic kidney disease
(Cr >1.5)
6 (14) 7 (39) .043
Dialysis dependent 1 (2) 0 (0) 1.000
COPD 9 (21) 5 (28) 1.000
Smoking history 35 (81) 13 (72) .499
Cerebrovascular disease 18 (42) 8 (44) 1.000
Peripheral vascular disease 21 (49) 10 (56) .780
BMI, Body mass index; CAD, coronary artery disease; CHF, congestive
heart failure; COPD, chronic obstructive pulmonary disease; Cr, creatinine;
PA, pseudoaneurysm.
Boldface entries indicate P # .05.
Table II. Anticoagulation regimens
Negative PA
(n ¼ 43)
Positive PA
(n ¼ 18) P value
Preprocedure antiplatelet
therapy
Aspirin 22 7 .414
Clopidogrel 1 0 1.000
Aspirin and clopidogrel 15 10 .161
None 5 1 .660
Periprocedural
anticoagulation therapy
Heparin 31 15 .518
Bivalirudin 2 0 1.000
Heparin and bivalirudin 1 1 .507
NA 9 2 d
NA, Not applicable; PA, pseudoaneurysm.
Table III. Specialty performing procedure
Specialty
Negative PA
(n ¼ 43)
Positive PA
(n ¼ 18) P value
Vascular surgery 25 10 1.000
Cardiology 17 6 .775
Intravenous teama 0 2 .084
Anesthesiologyb 1 0 1.000
PA, Pseudoaneurysm.
aAttempted peripherally inserted central catheter line insertion.
bAttempted arterial line insertion.
Table IV. Procedure type
Procedure type
Negative PA
(n ¼ 43)
Positive PA
(n ¼ 18) P value
Visceral 9 6 .304
Lower extremity 15 4 .381
Coronary 18 6 .579
Other 1a 2b .206
PA, Pseudoaneurysm.
aAttempted arterial line insertion.
bAttempted peripherally inserted central catheter line insertion.
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coagulation therapy is not suspended for the purpose of TI.
All injections were performed by fellowship-trained
vascular surgeons or by vascular surgery fellows under
direct supervision of the attending surgeon.
Treatment success was deﬁned as (1) complete initial
thrombosis of the PA visualized in real time with duplex
ultrasound, (2) preserved thrombosis of the PA the
following day by duplex ultrasound, and (3) no evidence
of local thrombotic or distal ischemic complications noted
the following day. Statistical analysis by Fisher exact test for
categorical variables and Student t-test for continuous vari-
ables was performed with GraphPad (www.graphpad.com)
online statistical software.
RESULTS
Between January 1, 2009, and December 31, 2012,
there were 61 upper extremity arterial duplex examinationsperformed for a clinical suspicion of a postprocedure PA.
Of the index procedures, there were 35 vascular surgery pro-
cedures and 23 cardiology procedures. Also in the group
were two attempted insertions of a peripherally inserted cen-
tral catheter (PICC) line by the intravenous team and one
attempted arterial line placement by an anesthesiologist.
Documented clinical suspicion of a PA included one or
more of the following signs or symptoms: ecchymosis (eight
patients), pain or tenderness (seven patients), hematoma
(four patients), abnormal pulsatility or palpable mass (four
patients), and symptoms of nerve compression (two
patients). Of the 61 duplex examinations, 18 (29.5%)
demonstrated an iatrogenic upper extremity PA and 43
(70.5%) did not. There were 13 PAs involving the distal
brachial artery and ﬁve involving the distal radial artery.
Compared with those patients who did not have a PA,
those who did develop a PA were more likely to have a his-
tory of hypertension, atrial ﬁbrillation, and chronic kidney
disease (Table I). There was also a trend toward older
age and female gender as risk factors for development of
a PA, but these did not reach statistical signiﬁcance in
our analysis. When considering sheath size as a potential
risk factor for PA development, we found that a larger
sheath size ($5F) did not portend a greater risk for devel-
opment of a PA (81.4% negative group vs 72.2% positive
group; P ¼ .499). Similarly, the location of arterial access
(brachial 65.1% negative group vs brachial 72.2% positive
group; P ¼ .767), the type of preoperative antiplatelet
regimen (Table II), the type of intraoperative anticoagula-
tion regimen (Table II), the service specialty performing
the procedure (Table III), and the type of procedure per-
formed (Table IV) had no inﬂuence on development of
an upper extremity PA.
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with TI (two were treated with immediate surgical repair
and two were treated with observation at the discretion
of the attending surgeon). Nine of these 14 patients had
atrial ﬁbrillation, and each had the anticoagulation held
before the index procedure; however, two patients had
international normalized ratio values >1.5 at the time of
the index procedure. The average size of the PAs in this study
was 1.9 cm (range, 0.6-7.0 cm) in greatest dimension. The
mean injected thrombin dose was 2079 IU (range, 300-
8000 IU; median, 1000 IU). If the two patients with exces-
sively large doses (6000 IU and 8000 IU because of large PA
size) were excluded from analysis, the mean injected
thrombin dose was 1258 IU with a median of 1000 IU.
Two of the 14 patients treated with TI were treated as out-
patients and 12 were treated as inpatients.
Technical success was achieved in 12 of the 14 patients
(86%) treated with TI. One treatment failure occurred in a
93-year-old man who had a 7-cm brachial artery PA after
attempted PICC line placement with inadvertent puncture
of the brachial artery. This patient had 6000 IU of
thrombin injected at the time of treatment with partial
thrombosis of the PA noted; but the PA had failed to
completely thrombose by the following day, so he was
taken to surgery for open repair. The other treatment fail-
ure occurred in a critically ill 75-year-old woman who pre-
sented with an embolic stroke followed by clinical signs of
acute mesenteric ischemia. She underwent emergent supe-
rior mesenteric artery percutaneous thrombectomy and
stenting through a left brachial artery approach. She devel-
oped a 7.5-mm PA at the left brachial artery access site the
following day. After successful injection and thrombosis of
the PA, there was noted to be a focal brachial artery throm-
bosis at the site with a reduction in the amplitude of the
distal Doppler waveforms 15 minutes after injection. The
patient was taken immediately to the operating room for
open surgical revascularization of the brachial artery. Ten
days later, owing to the magnitude of her stroke, the
patient was made comfort measures only and died.
Of the 12 patients with successful TI, outpatient clin-
ical follow-up in the vascular surgery clinic was performed
on 11 patients. The average length of subsequent outpa-
tient vascular surgery follow-up was 8 months (range,
1-37 months) from the date of PA injection. Follow-up
consisted of clinical examination by the attending vascular
surgeon without routine vascular laboratory testing. No
PA recurrences based on physical examination ﬁndings
were identiﬁed on outpatient follow-up. No cases of
delayed complications, including distal embolization,
native artery thrombosis, infection, or allergic reaction,
were identiﬁed. Of note, the two patients who presented
with symptoms of nerve compression both experienced
persistent but improved neurapraxia at 3 months and
37 months, respectively.
DISCUSSION
To our knowledge, although this is a small series, it is
the largest study examining the utility of TI for iatrogenicupper extremity PAs. The study showed that TI is techni-
cally feasible with an initial technical success rate of 86%,
with one treatment failure and one native artery thrombosis
each occurring in patients who were deemed high risk for
open surgical repair. Regarding the ﬁrst treatment failure
in the 93-year-old man with the 7-cm PA, we submit
that most patients with a PA of this size would have under-
gone primary open repair; but because of this person’s age,
we thought an attempt at percutaneous intervention was
warranted. Regarding the second patient who developed
brachial artery thrombosis after TI, review of her duplex
imaging revealed very little or no neck; but given her over-
all poor clinical condition at the time of PA diagnosis, the
decision was made by the treating physician to attempt a
high-risk injection that resulted in brachial artery throm-
bosis as well as PA thrombosis. These two treatment fail-
ures highlight some of the limitations of TI and
emphasize the need to exercise proper selection bias in per-
forming these procedures. Overall, the success rate in our
series would indicate that this procedure is both safe and
effective as initial treatment of upper extremity PAs, with
only one complication (7%) that resulted in the need for
emergent surgical repair to treat a thrombosed brachial
artery. Moreover, outpatient clinical follow-up with a
vascular surgeon identiﬁed no PA recurrence at a mean
of 8 months, demonstrating the procedure to be durable.
Currently, little literature exists to document the durability
of this procedure, although most vascular practitioners are
likely to agree that once the PA is thrombosed, the risk of
recurrence is generally considered low. The results of this
study support this assumption.
The majority of the patients in the PA group in our
study were female (64.3%); sheath sizes were $5F
(78.6%). Although these differences were not statistically
signiﬁcant, we ﬁrmly believe that larger sheath size and
female gender (because of smaller artery size) increase the
risk for development of a postprocedure upper extremity
PA. In support of our belief, Alvarez-Tostado et al10 found
that the female gender was the only factor associated with a
higher rate of access site complications during brachial
artery access for endovascular procedures. We also believe
that advanced age is a risk factor for development of a
PA; but in our study, the small sample size probably pre-
vented a statistically signiﬁcant result with a P value of
.055. Comparable to female gender and sheath size in
this study, the presence or absence of a postprocedure
PA did not differ on the basis of the location of the vascular
access (brachial vs radial). This ﬁnding, although inter-
esting, may be a result of decreased access site complica-
tions after transradial access. We suspect that the lower
morbidity of radial artery access, combined with lessened
clinical suspicion, resulted in a small percentage of transra-
dial access patients being referred for a postprocedure ultra-
sound examination. This potential confounder, combined
with the small number of patients with an upper extremity
PA, probably accounted for the lack of a difference
between the study groups. Whereas this hypothesis is
unsubstantiated by our data set, it is supported by existing
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brachial artery access10-13 compared with transradial inter-
ventions.11,12,14 Last, there was no difference in the devel-
opment of PA on the basis of the medical specialty
performing the procedure, with most procedures per-
formed by vascular surgeons and cardiologists. Two PAs
were caused by attempted PICC line insertions by the
intravenous team, and one suspected PA was caused by
an arterial line insertion by an anesthesiologist, which
turned out to be negative.
Before this report, the largest case series of TI of upper
extremity PAs came from Kang et al4 and Krueger et al.5
The Kang series4 consisted of one subclavian, ﬁve brachial,
and one radial artery PA. This series differs from ours as it
consisted of traumatic PAs (ie, two gunshot wounds) as
well as one brachial artery PA after removal of an infected
arteriovenous graft. Of their seven upper extremity PAs un-
dergoing TI, treatment of one brachial artery PA resulted
in hand ischemia, which was successfully treated with sys-
temic heparin infusion and did not require an operation.
In addition to one incident of hand ischemia, there was
one early recurrence after TI of a brachial artery PA. The
Krueger series5 did not report the etiology of the eight
brachial artery PAs but reported a 100% success rate with
injection. To our knowledge, the largest series describing
treatment of upper extremity PAs is from Garg et al,15 in
which they examine open surgical management of arterial
complications after radial artery catheterization. In this
single-institution series, they identiﬁed 10 radial artery
PAs, all of which were repaired with traditional open sur-
gery. The authors reported no ischemic complications
but did report 60% of radial artery PAs to be associated
with an infectious etiology. In our series, we encountered
ﬁve radial artery PAs, none of which was related to an
underlying infection.
Because of the differences noted in our study compared
with those in the existing literature, we believe our study
adds valuable knowledge for practitioners treating upper
extremity arterial access site complications. Distal brachial
artery and distal radial artery PAs can be safely injected
with thrombin. We did not identify or inject any proximal
brachial artery or axillary artery PAs in our series where
there could be increased risk of neurologic injury from an
axillary sheath hematoma.
There are several limitations to this study, and the
results must be interpreted with these in mind. First, this
is a retrospective single-institution review, so important
data points may have been missed and the results may
not be generalizable to the population at large. Second,
the sample size is small, and important clinical associations
may have been missed because of the study’s being under-
powered. Third, we did not have a standard protocol for
determining which patients were acceptable candidates
for TI (PA size and neck length) but rather based
decision-making on clinical judgment of the surgeon per-
forming the procedure, so selection bias is therefore sus-
pected. Fourth, there was no imaging performed beyond
the follow-up duplex examination the day after TI, sotrue long-term clinical outcomes cannot be validated with
a radiologic study. It is possible, therefore, that recurrence
of small asymptomatic PAs could have been missed. Fifth,
data regarding anticoagulation reversal after the procedure
are lacking. There may be a higher risk of PA formation
when reversal agents such as protamine are not used, but
we were not able to extract these data for each patient in
our study. Finally, ultrasound duplex imaging was per-
formed only for patients who were symptomatic or had
worrisome physical examination ﬁndings after vascular
access procedures, so it is possible that some small asymp-
tomatic PAs may have been missed, therefore preventing us
from determining important risk factors for the develop-
ment of PAs in all patients who undergo upper extremity
arterial puncture.
CONCLUSIONS
In this small single-institution series, we have demon-
strated the technique of ultrasound-guided TI to be safe
and effective for the treatment of iatrogenic brachial and
radial artery PAs after vascular access procedures in the
upper extremities. Therefore, we would advocate the
consideration of use of this technique to treat iatrogenic
upper extremity PAs for those practitioners who are already
skilled at performing this technique for femoral artery PAs.
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